Zengin, R. Et Al. 2025. Serum Prolidase and Ischemia-Modified Albumin Levels in Neural Tube Defects: A Comparative Study of Myelomeningocele, Meningocele, and Myeloschisis. Medical Science Monitor , vol.31 .

Zengin, R., Akyol, M. E., Arslan, M., Arabacı, Ö., Yürektürk, E., Çetin, E., ... Demir, H.(2025). Serum Prolidase and Ischemia-Modified Albumin Levels in Neural Tube Defects: A Comparative Study of Myelomeningocele, Meningocele, and Myeloschisis. Medical Science Monitor , vol.31.

Zengin, Rfan Et Al. "Serum Prolidase and Ischemia-Modified Albumin Levels in Neural Tube Defects: A Comparative Study of Myelomeningocele, Meningocele, and Myeloschisis," Medical Science Monitor , vol.31, 2025

Zengin, Rfan Et Al. "Serum Prolidase and Ischemia-Modified Albumin Levels in Neural Tube Defects: A Comparative Study of Myelomeningocele, Meningocele, and Myeloschisis." Medical Science Monitor , vol.31, 2025

Zengin, R. Et Al. (2025) . "Serum Prolidase and Ischemia-Modified Albumin Levels in Neural Tube Defects: A Comparative Study of Myelomeningocele, Meningocele, and Myeloschisis." Medical Science Monitor , vol.31.

@article{article, author={Rfan Zengin Et Al. }, title={Serum Prolidase and Ischemia-Modified Albumin Levels in Neural Tube Defects: A Comparative Study of Myelomeningocele, Meningocele, and Myeloschisis}, journal={Medical Science Monitor}, year=2025}